Apolipoprotein A-I mimetic peptide D-4F promotes human endothelial progenitor cell proliferation, migration, adhesion though eNOS/NO pathway

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4445-4454

  Zhang, Zhengang ^a,b   Qun, Jianhua ^a   Cao, Chunmei ^a   Wang, Jun ^a   Li, Wei ^a   Wu, Yong ^a   Du, Lin ^a   Zhao, Pei ^a   Gong, Kaizheng ^a  

^a YANGZHOU UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Apolipoprotein A I; D 4F; Endothelial nitric oxide synthas; Endothelial progenitor cells; Nitric oxide

Indexed keywords

AGENTS AFFECTING METABOLISM; APOLIPOPROTEIN A1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; PEPTIDE D 4F; UNCLASSIFIED DRUG; D 4F PEPTIDE; D-4F PEPTIDE; NITRIC OXIDE; NOS3 PROTEIN, HUMAN;

ADULT; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIAL PROGENITOR CELL; ENZYME SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID TRANSPORT; MALE; MOLECULAR DYNAMICS; PROTEIN EXPRESSION; WESTERN BLOTTING; BIOSYNTHESIS; CELL MOTION; CYTOLOGY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYMOLOGY; METABOLISM; SIGNAL TRANSDUCTION; STEM CELL;

ULEX EUROPAEUS;

ADULT; APOLIPOPROTEIN A-I; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; ENDOTHELIAL CELLS; ENZYME ACTIVATION; HUMANS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84863000104     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1233-0     Document Type: Article

References (45)

1. Van Lenten B, Wagner A, Anantharamaiah G, Navab M, Reddy S, Buga G, Fogelman A (2009) Apolipoprotein A-I mimetic peptides. Curr Atheroscler Rep 11:52-57
2. Getz GS, Wool GD, Reardon CA (2009) Apoprotein A-I mimetic peptides and their potential anti-atherogenic mechanisms of action. Curr Opin Lipidol 20:171-175
3. Sherman CB, Peterson SJ, Frishman WH (2010) Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis. Cardiol Rev 18:141-147
4. Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D et al (2004) Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109:3215-3220
5. Kruger AL, Peterson S, Turkseven S, Kaminski PM, Zhang FF, Quan S, Wolin MS, Abraham NG (2005) D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes. Circulation 111:3126-3134
6. Timmermans F, Plum J, Yöder MC, Ingram DA, Vandekerckhove B, Case J (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87-102
7. Lamping K (2007) Endothelial progenitor cells: sowing the seeds for vascular repair. Circ Res 100:1243-1245
8. Steinmetz M, Nickenig G, Werner N (2010) Endothelial-regenerating cells: an expanding universe. Hypertension 55:593-599
9. Zhu J, Wang X, Chen J, Sun J, Zhang F (2006) Reduced number and activity of circulating endothelial progenitor cells from patients with hyperhomocysteinemia. Arch Med Res 37:484-489
10. Zhang L, Liu W, Chen Y, Song X, Jin Z, Lu S (2010) Proliferation, migration and apoptosis activities of endothelial progenitor cells in acute coronary syndrome. Chin Med J 123:2655-2661
11. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. New Engl J Med 353: 999-1007
12. Schachinger V, Assmus B, Britten MB, Honold J, Lehmann R, Teupe C, Abolmaali ND, Vogl TJ, Hofmann W-K, Martin H et al (2004) Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol 44:1690-1699
13. Wang J, Zhang S, Rabinovich B, Bidaut L, Soghomonyan S, Alauddin MM, Bankson JA, Shpall E, Willerson JT, Gelovani JG et al (2010) Human CD34? cells in experimental myocardial infarction: long-term survival, sustained functional improvement, and mechanism of action. Circ Res 106:1904-1911
14. Hu C, Li Z, Du Z, Zhang A, Yang DY, Wu GF (2009) Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction. Chin Med J 122:548-555
15. Forstermann U, Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714
16. Feng Y, Jacobs F, Van Craeyveld E, Brunaud C, Snoeys J, Tjwa M, Van Linthout S, De Geest B (2008) Human ApoA-I transfer attenuates transplant arteriosclerosis via enhanced incorporation of bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:278-283
17. Salvatore P, Casamassimi A, Sommese L, Fiorito C, Ciccodicola A, Rossiello R, Avallone B, Grimaldi V, Costa V, Rienzo M et al (2008) Detrimental effects of Bartonella henselae are counteracted by L-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci USA 105:9427-9432
18. Casamassimi A, Balestrieri ML, Fiorito C, Schiano C, Maione C, Rossiello R, Grimaldi V, Del Giudice V, Balestrieri C, Farzati B et al (2007) Comparison between total endothelial progenitor cell isolation versus enriched cd133?culture. J Biochem 141:503-511
19. Miguel-Velado E, Pérez-Carretero FD, Colinas O, Cidad P, Heras M, López-López JR, Pérez-García MT (2010) Cell cycledependent expression of Kv3.4 channels modulates proliferation of human uterine artery smooth muscle cells. Cardiovasc Res 86: 383-391
20. Zhang Y, Liu D, Chen X, Li J, Li L, Bian Z, Sun F, Lu J, Yin Y, Cai X et al (2010) Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell 39:133-144
21. Gong K, Li Z, Xu M, Du J, Lv Z, Zhang Y (2008) A novel protein kinase A-independent, beta-arrestin-1-dependent signaling pathway for p38 mitogen-activated protein kinase activation by beta2-adrenergic receptors. J Biol Chem 283:29028-29036
22. Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352-1364
23. Zhu J, Tao Q, Chen J, Wang X, Zhu J, Shang Y (2004) Statins contribute to enhancement of the number and the function of endothelial progenitor cells from peripheral blood. Acta Physiol Sin 56:357-364
24. Petoumenos V, Nickenig G, Werner N (2009) High-density lipoprotein exerts vasculoprotection via endothelial progenitor cells. J Cell Mol Med 13:4623-4635
25. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA (2004) High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc Natl Acad Sci USA 101:6999-7004
26. D'Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D (2010) Structure/function relationships of apolipoprotein A-I mimetic peptides: implications for anti-atherogenic activities of highdensity lipoprotein. Circ Res 107:217-227
27. Alev C, Ii M, Asahara T (2011) Endothelial progenitor cells: a "novel"tool for the therapy of ischemic diseases. Antioxid Redox Signal 15:949-965
28. White CR, Datta G, Mochon P, Zhang Z, Kelly O, Curcio C, Parks D, Palgunachari M, Handattu S, Gupta H, Garber DW, Anantharamaiah GM (2009) Vasculoprotective effects of apolipoprotein mimetic peptides: an evolving paradigm in HDL therapy. Vasc Dis Prev 6:122-130
29. Xu J, Zou M-H (2009) Molecular insights and therapeutic targets for diabetic endothelial dysfunction. Circulation 120:1266-1286
30. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T (2003) Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 348:593-600
31. Briguori C, Testa U, Riccioni R, Colombo A, Petrucci E, Condorelli G, Mariani G, D'Andrea D, De Micco F, Rivera NV et al (2010) Correlations between progression of coronary artery disease and circulating endothelial progenitor cells. FASEB J 24: 1981-1988
32. Liao Y, Chen L, Zeng T, Li Y, Fan Y, Hu L, Ling Y (2010) Number of circulating endothelial progenitor cells as a marker of vascular endothelial function for type 2 diabetes. Vasc Med 15:279-285
33. Leone AM, Valgimigli M, Giannico MB, Zaccone V, Perfetti M, Damario D, Rebuzzi AG, Crea F (2009) From bone marrow to the arterial wall: the ongoing tale of endothelial progenitor cells. Euro Heart J 30:890-899
34. Noor R, Shuaib U, Wang CX, Todd K, Ghani U, Schwindt B, Shuaib A (2007) High-density lipoprotein cholesterol regulates endothelial progenitor cells by increasing eNOS and preventing apoptosis. Atherosclerosis 192:92-99
35. Peterson SJ, Husney D, Kruger AL, Olszanecki R, Ricci F, Rodella LF, Stacchiotti A, Rezzani R, McClung JA, Aronow WS et al (2007) Long-term treatment with the apolipoprotein A-1 mimetic peptide increases antioxidants and vascular repair in type I diabetic rats. J Pharmacol Exp Ther 322:514-520
36. Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM (2002) Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105:290-292
37. Wool GD, Cabana VG, Lukens J, Shaw PX, Binder CJ, Witztum JL, Reardon CA, Getz GS (2010) 4F Peptide reduces nascent atherosclerosis and induces natural antibody production in apolipoprotein E-null mice. FASEB J 25:290-300
38. Jiang H, Chen SS, Yang J, Chen J, He B, Zhu LH, Wang L (2011) CREB-binding protein silencing inhibits thrombin-induced endothelial progenitor cells angiogenesis. Mol Biol Rep. doi: 10.1007/s11033-011-1035-4
39. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, Krasich R, Temm CJ, Prchal JT, Ingram DA (2007) Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801-1809
40. Feng Y, Gordts SC, Chen F, Hu Y, Van Craeyveld E, Jacobs F, Carlier V, Feng Y, Zhang Z, Xu Q et al (2011) Topical HDL administration reduces vein graft atherosclerosis in apo E deficient mice. Atherosclerosis 214:271-278
41. Feng Y, Van Eck M, Van Craeyveld E, Jacobs F, Carlier V, Van Linthout S, Erdel M, Tjwa M, De Geest B (2009) Critical role of scavenger receptor-BI-expressing bone marrow-derived endothelial progenitor cells in the attenuation of allograft vasculopathy after human apo A-I transfer. Blood 113:755-764
42. Hamed S, Brenner B, Roguin A (2011) Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. Cardiovasc Res 91:9-15
43. Ma FX, Zhou B, Chen Z, Ren Q, Lu SH, Sawamura T, Han ZC (2006) Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res 47:1227-1237
44. Yu X, Song M, Chen J, Zhu G, Zhao G, Wang H, Hunag L (2010) Hepatocyte growth factor protects endothelial progenitor cell from damage of low-density lipoprotein cholesterol via the PI3K/Akt signaling pathway. Mol Biol Rep 37:2423-2429
45. Seetharam D, Mineo C, Gormley AK, Gibson LL, Vongpatanasin W, Chambliss KL, Hahner LD, Cummings ML, Kitchens RL, Marcel YL et al (2006) High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ Res 98:63-72